Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tyrosine kinase inhibitors and their unique therapeutic potentialities to combat cancer
Yuping Zhao, Muhammad Bilal, Ali Raza, et al.
International Journal of Biological Macromolecules (2020) Vol. 168, pp. 22-37
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
Ahmed Elkamhawy, Qili Lu, Hossam Nada, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6535-6535
Open Access | Times Cited: 74
Optimization and characterization studies of poultry waste valorization for peptone production using a newly Egyptian Bacillus subtilis strain
Hesham Saeed, Anthony Ragaey, Ziad Samy, et al.
AMB Express (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
The Development of BTK Inhibitors: A Five-Year Update
Bruno Tasso, Andrea Spallarossa, Eleonora Russo, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7411-7411
Open Access | Times Cited: 51
Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
Harpinder Kaur Brar, Jiney Jose, Zimei Wu, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 59-59
Open Access | Times Cited: 31
Chitosan nanoparticles as a smart nanocarrier for gefitinib for tackling lung cancer: Design of experiment and in vitro cytotoxicity study
Haitham Amin, Mohammed A. Amin, Shaaban K. Osman, et al.
International Journal of Biological Macromolecules (2023) Vol. 246, pp. 125638-125638
Closed Access | Times Cited: 21
Chromatographic and mass spectrometric analytical strategies for profiling tyrosine kinase inhibitors in biological samples
Jing Ye, Mengxin Bi, Huan Yao, et al.
Microchemical Journal (2024) Vol. 201, pp. 110694-110694
Closed Access | Times Cited: 6
Role of circular RNAs in disease progression and diagnosis of cancers: An overview of recent advanced insights
Safir Ullah Khan, Munir Ullah Khan, Muhammad Imran Khan, et al.
International Journal of Biological Macromolecules (2022) Vol. 220, pp. 973-984
Closed Access | Times Cited: 26
Novel antiproliferative agents bearing substituted thieno[2,3-d]pyrimidine scaffold as dual VEGFR-2 and BRAF kinases inhibitors and apoptosis inducers; design, synthesis and molecular docking
Rasha A. Hassan, Maha M. Abdel‐Fattah, Amr M. Abdou, et al.
Bioorganic Chemistry (2022) Vol. 125, pp. 105861-105861
Open Access | Times Cited: 20
A unified platform enabling biomarker ranking and validation for 1562 drugs using transcriptomic data of 1250 cancer cell lines
János Tibor Fekete, Balázs Győrffy
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 2885-2894
Open Access | Times Cited: 20
Trends in Nanotechnology to improve therapeutic efficacy across special structures
Muhammad Imran Khan, Qurat ul ain Zahra, Fakhra Batool, et al.
OpenNano (2022) Vol. 7, pp. 100049-100049
Open Access | Times Cited: 19
Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients
Soumik Das, Achsha Babu, Tamma Medha, et al.
Medical Oncology (2023) Vol. 40, Iss. 5
Open Access | Times Cited: 13
Development and fabrication of a novel nano-bilosomal system for enhanced oral delivery of Trametinib: apoptotic induction and anticancer efficacy evaluation
Ananda Kumar Chettupalli, Suryanarayana Chokkarapu, Ankit Singh, et al.
Materials Technology (2025) Vol. 40, Iss. 1
Open Access
Research Progress of Natural Small-Molecule Compounds Related to Tumor Differentiation
Xiaoli He, Yongkang Liao, Jing Liu, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2128-2128
Open Access | Times Cited: 15
Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies
Ashraf K. El‐Damasy, Hyun Ji Kim, Ahmed A. Al‐Karmalawy, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 427-427
Open Access | Times Cited: 3
Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents
David L. Brautigan, Caroline Farrington, Goutham Narla
Clinical Science (2021) Vol. 135, Iss. 13, pp. 1545-1556
Open Access | Times Cited: 18
Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors
Motahareh Mortazavi, Masoumeh Divar, Tahereh Damghani, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 14
Insight of nanomedicine strategies for a targeted delivery of nanotherapeutic cues to cope with the resistant types of cancer stem cells
Yangyong Mao, Mahpara Qamar, Sarmad Ahmad Qamar, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 64, pp. 102681-102681
Closed Access | Times Cited: 17
Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer
Huafeng Jiang, Senjun Zhou, Gang Li
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
A New Antitumor Direction: Tumor-Specific Endothelial Cells
Jing Liang, Shouqi Wang, Guowei Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13
Role of ionizing radiation activated NRF2 in lung cancer radioresistance
Qianqian Xu, Peiyu Zhang, Xiaoyan Han, et al.
International Journal of Biological Macromolecules (2023) Vol. 241, pp. 124476-124476
Closed Access | Times Cited: 5
A review of computational studies and bioinformatics analysis of effective drug as an inhibitor against EGFR/VEGFR-2 kinases
Mona H. Ibraheim, Ibrahim Maher, Ibrahim Khater
Bulletin of Faculty of Science Zagazig University (2024) Vol. 2024, Iss. 1, pp. 143-155
Open Access | Times Cited: 1
Advances in chalcone-based anticancer therapy: mechanisms, preclinical advances, and future perspectives
Shefali Chowdhary, Preeti Preeti, Shekhar Shekhar, et al.
Expert Opinion on Drug Discovery (2024)
Closed Access | Times Cited: 1
Nanotechnology-based immunotherapies to combat cancer metastasis
Yuping Zhao, Muhammad Bilal, Maimoona Qindeel, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 9, pp. 6563-6580
Closed Access | Times Cited: 10
A Simple UPLC/MS-MS Method for Simultaneous Determination of Lenvatinib and Telmisartan in Rat Plasma, and Its Application to Pharmacokinetic Drug-Drug Interaction Study
Yanjun Cui, Ying Li, Li Xiao, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1291-1291
Open Access | Times Cited: 7
Intelligent porphyrin nano-delivery system for photostimulated and targeted inhibition of angiogenesis
Yan Jiao, Ye Gao, JiaYao Wang, et al.
International Journal of Pharmaceutics (2022) Vol. 621, pp. 121805-121805
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top